Abstract Pdx-1 and Irs-1, genes highly associated with diabetes onset, were knocked down in mouse embryonic stem (ES) cells in order to develop cell line models for diabetes. ES cells with different gene knockdown levels were induced to differentiate to the stage of insulin production. Among the cell lines that differentiated, we identified two in which the levels of expression of both genes were 20-40 % of that of control cells. These cell lines showed appreciable deficiencies in three characteristic malfunctions associated with diabetes, namely, insulin production, insulin reception signaling, and glucose-stimulated insulin secretion. These dysfunctions were consistent with results reported elsewhere from in vivo and in vitro studies. Both cell lines did not show any abnormal morphology such as size, shape, color, and surface roughness. No abnormal expression profiles for 17 genes relevant to diabetes were observed. Therefore, these cell lines fulfilled the criteria for a validated cell model for diabetes. The model cell lines developed here are promising biomaterials for cellbased screening tests of new medicines that may be effective in treating diabetes.
Introduction
There is an urgent need for viable cell-based screening methods to test new drugs with potential for use in the management and treatment of diabetes. Such cellbased methods are required to be responsive to the effects of candidate drugs across the range of dysfunctions associated with diabetes. The principal effects of the disease in vivo are deficiencies in insulin production, insulin reception, and glucose-stimulated insulin secretion (GSIS). GSIS is a combination of glucose reception and insulin secretion functions. A number of studies have examined the genetic basis of diabetes and identified specific genes for insulin production (Melloul et al. 2001) , insulin reception (Kubota et al. 2008; Guo et al. 2009; Dobrzyn et al. 2010) , and GSIS (Pal 2009; Bennett et al. 2010) . It has been speculated that the genes for these various roles are functionally linked. From the standpoint of screening candidate drugs, it is important for model cell lines to be sensitive to the effect of candidate drugs on any of these dysfunctions.
Our strategy is to selectively knock down expression of genes that are involved in the dysfunctions described above. It is known that a number of genes contribute to the risk of diabetes, and several cases of double gene knockout, such as Pdx-1 and Irs-1 (Kulkarni et al. 2004) , Pdx-1 and HNF-1a (Shih et al. 2002) , Irs-1 and Gk (Terauchi et al. 1997) , Kir6.2 and Irs-2, Gk and Shp, have been reported to be suspected to cause diabetes in mice.
In order to achieve a quantitative regulation of multiple genes, we adopted RNAi-based knockdown methodologies (Santoyo et al. 2005; Sliva and Schnierle 2010; Li and Mahato 2011) . We first sought to identify RNAi sequences that were effective at knocking down the genes listed above. RNAi sequences against every gene except Gk were developed (unpublished data). Two of the genes, Pdx-1 and Irs-1, were then selected for the development of double knockdown cell lines.
Pdx-1 has a well-understood and central role in insulin production by directly activating insulin production genes such as Ins1 and Ins2 (Melloul et al. 2001) . It has been speculated that Pdx-1 can regulate the size of the b-cell mass and also the insulin production activity of each b-cell, so as to maintain insulin levels within the required range (McKinnon and Docherty 2001; Melloul et al. 2002; Gannon et al. 2008) . The available data all point to Pdx-1 having a role as a general stabilizer of the insulin production level. When the insulin production level goes up to such an abnormally high level as after loss of Irs-1, it is possible that Pdx-1 might act to reduce insulin production to the normal level.
Irs-1 is involved in insulin reception deficiency (insulin resistance). Insulin resistance is observed not only in the cells of peripheral organs, such as hepatocytes and skeletal muscle cells (Wada et al. 2009; Franchini et al. 2010; Ketsawatsomkron et al. 2010 ), but also in pancreatic b-cells (Terauchi et al. 2007 ). Typically in b-cells, insulin resistance is caused by an insufficiency of Irs-1, which encodes a protein that is a substrate of tyrosine kinase. Irs-1 constitutes the intracellular part of the insulin receptor and plays a role in signal transduction from insulin reception to several downstream pathways (Guo et al. 2009 ). In these pathways, Irs-2 is of particular interest. Irs-2 expression is activated in compensation for the loss of Irs-1 function (Kubota et al. 2008; Dobrzyn et al. 2010; González-Rodríguez et al. 2010; Yang et al. 2010) . Following its activation, Irs-2 stimulates expression of further downstream genes associated with insulin production. This activation cascade often leads to an abnormal increase in b-cell mass and islet hyperplasia. Such an abnormal response is thought to be facilitated by Pdx-1 (Kulkarni et al. 2004) .
The current understanding of the principal pathway for GSIS is as follows: a blood glucose increase is first detected by pancreatic b-cells. The b-cells, which produce and store insulin, respond to the glucose increase by secreting insulin into the blood via ATPdependent K ? channel closure, Ca 2? influx, the fusion of insulin stored vesicles with the cell membrane, and the final step of insulin secretion. Blood insulin is then transferred to and detected by peripheral cells such as hepatocytes and skeletal muscle cells. These cells remove glucose from the blood and lower the blood glucose levels. The reduction in blood glucose is detected by the b-cells and, finally, insulin secretion slows down. This pathway therefore constitutes an in vivo feedback regulation cycle. The principal genes involved in this cycle are Gk, a glucose sensor, and Kir6.2, a subunit of an ATP-dependent K ? channel. Since Gk is known to be partially regulated by Pdx-1 (Watada et al. 1996) , the dysfunction of GSIS is thought to be caused by Pdx-1 deficiency.
In light of the available information, we speculated that a double knockdown of Pdx-1 and Irs-1 would provide a model cell system for the principal dysfunctions associated with diabetes. The goal of this study was to establish ES cell lines in which expression of both genes was knocked down to levels that were not too low to inhibit their differentiation into b-like insulin producing cells but not so high that dysfunctions associated with diabetes were not manifested.
Methods

Mouse ES cell culture and transfection
A feeder-free mouse ES cell line (EB3) was obtained from H. Niwa (RIKEN, Kobe, Japan) and cultured in ES cell medium (ESM) in gelatin-coated dishes. ESM is composed of Glasgow minimum essential medium, 10 % fetal bovine serum, 19 non-essential amino acids, 200 mM L-glutamine, 1 mM sodium pyruvate, 10 -4 M 2-mercaptoethanol and 1,000 U/ml leukemia inhibitory factor (LIF). For transfection, 1 9 10 7 ES cells in a 0.4 cm cuvette were electroporated with 50 lg of linearized plasmid DNA at 800 V and 3 lF using a Bio-Rad gene pulser. Selection was carried out using 100-200 lg/ml hygromycin or 100-300 lg/ml G418 (Sigma-Aldrich, Saint Louis, MO) for 7-10 days.
Preparation of shRNA expression vector
At first we developed ES cell lines in which the expression of Pdx-1 or Irs-1 was visualized by means of a fluorescent reporter protein, EGFP. Since this check should be performed in ES cells, undifferentiated state, we used a promoter such as CAG applicable to the constant expression of those genes in ES cells. In the transfection vector, the CAG promoter was followed by the sequences of Pdx-1 (or Irs-1), IRES, and EGFP in tandem. In these cells, equimolar Pdx-1 (or Irs-1) and EGFP proteins are thought to be generated. These cell lines were designated as Pdx-1:EGFP and Irs-1:EGFP. Several candidate RNAi sequences against Pdx-1 or Irs-1 were designed using siSearch (Chalk et al. 2004 ) and applied to Pdx-1:EGFP or Irs-1:EGFP. The effectiveness of the RNAi sequences was evaluated by monitoring EGFP fluorescence intensities and the optimum siRNA sequences against Pdx-1 and Irs-1 were determined. Based on these siRNA sequences, the optimum shRNAs against Pdx-1 (shRNA Pdx-1 ) and Irs-1 (shRNA Irs-1 ) were designed (Fig. 1a-c) . Vectors expressing shRNA Pdx-1 or shRNA Irs-1 were prepared by inserting the appropriate hair-pin type sequences into pSilencer3.1-H1-hygro vector or pSilencer3.1-H1-neo vector (Ambion, Austin, TX, USA) (Fig. 1d) . The shRNA Pdx-1 expression vector, pshRNA Pdx-1 -hygro, was introduced into Pdx-1:EGFP. The shRNA Irs-1 expression vector, pshRNA Irs-1 -neo(21mer) or pshRNA Irs-1 -neo(29mer), was introduced into Irs-1:EGFP. 21mer and 29mer indicate the chain lengths of the active form of the siRNA produced in the cells. Preliminary experiments suggested that activity of siRNA Irs-1 was greatest at these chain lengths. Therefore, we used these 2 different vectors for shRNA . Consequently the fluorescent intensity decreased markedly in comparison with that of the control cell line. These indicated that shRNA Pdx-1 and shRNA Irs-1 expression vectors actually caused the decrease of Pdx-1 and Irs-1 proteins.
Based on these preliminary experiments, we finally prepared optimum knockdown cell lines by introducing the shRNA Pdx-1 expression vector or the shRNA Irs-1 expression vector into EB3 cells by electroporation.
In parallel with these cell lines, we prepared 2 kinds of controls: negative control cell lines and non-vector control cells. The negative control cell lines NC-1, NC-2, and NC-3 were established by introducing a pSilencer3.1-H1-hygro, a pSilencer3.1-H1-neo vector, and both vectors into EB3 cells, respectively. The non-vector control cells EB3 cells that had not been transfected with a vector.
Evaluation of the effects of shRNA expression vectors against Pdx-1 and Irs-1
Since Pdx-1 is not expressed in ES cells, the effect of shRNA Pdx-1 on intrinsic expression of Pdx-1 was evaluated at stage 4 of the differentiation process (defined below). The effect of shRNA Irs-1 on the expression of Irs-1 was evaluated at differentiation stages 2 and 4.
In vitro differentiation ES cells were induced to differentiate into insulin producing cells as previously described (Moritoh et al. 2003) . Briefly, the procedure has 4 stages: stage 1, 2-3 days culture in ESM for multiplication; stage 2, suspension culture in ESM for 4-5 days to obtain embryoid bodies; stage 3, selection of nestin-positive cells; stage 4, induction of insulin producing cells. Selection at stage 3 was performed by suspending embryoid bodies in DMEM (Gibco/BRL) containing 10 % fetal bovine serum (FBS) and culturing for 2 days. The medium was then replaced by DMEM/ F-12 (Gibco/BRL) and 509 ITSFn (Gibco/BRL) and the culture continued for 4-7 days. The cells were dislodged from culture dishes by treatment with 100 ll of 0.1 % trypsin/EDTA and then suspended in 1 ml ESM. The cells were collected by centrifugation (1,000 rpm, 3 min) and washed twice with 3 ml phosphate buffer saline (PBS). At stage 4, the cells were suspended in differentiation inducing medium (DIM), centrifuged, then re-suspended in fresh DIM. DIM is DMEM/F12 (Gibco/BRL) containing 50 9 N2 (Gibco/BRL), 10 ng/ml human keratinocyte growth factor (PeproTech), 25 ng/ml basic fibroblast growth factor (R&D Systems), 20 ng/ml epidermal growth factor (Sigma), 50 9 B27 supplement (Invitrogen), and 10 ng/ml nicotinamide. They were transferred to gelatin-coated dishes at a concentration of 0.5 -2.0 9 10 5 cells/cm 2 . The culture was continued for 6-8 days, and the culture medium was refreshed every 24 h. Cytotechnology (2013) 65:105-118 107
RNA isolation, RT-PCR and quantitative real-time RT-PCR (qRT-PCR)
Total RNA was prepared with ISOGEN reagent (Nippongene, Tokyo, Japan) according to the manufacturer's instructions. Oligo(dT)-primed cDNA was prepared from 1 lg of total RNA using SuperScript reverse transcriptase (Clontech-Takara Bio, Otsu, Japan). The primers for RT-PCR were designed using the information described in Moritoh et al. (2003) or mouse sequences reported elsewhere. The primer sequences used here are listed in Table 1 . PCR products were separated by agarose gel electrophoresis and visualized with ethidium bromide. qRT-PCR was performed with SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA) using the ABI Prism 7000 Sequence Detection System (Applied Biosystems). The amount of target RNA was normalized against Gapdh mRNA. The following primer pair sequences were used: Immunostaining of insulin producing cells
After stage 4, the culture medium was removed and the cells attached to the bottom of the dish were washed with PBS. The cells were fixed by addition of 2 ml of 4 % paraformaldehyde for 45 min. The fixed cells were washed three times with PBS and then treated with 100 % ethanol to permeabilize the cell membrane. The cells were washed three times with a glycerol/PBS solution and with 2 % gelatin for 15 min. Finally, the cells were washed three times with a glycerol/PBS solution and placed in a PBS solution containing 0.1 % bovine serum albumin (BSA) for 5 min. After removal of the BSA/PBS solution, guinea pig anti-mouse insulin antibody and rat anti-mouse C-peptide antibody were added to the dish. The cells were incubated with the antibodies at 37°C for 40 min. The reaction solution was then removed and the cells were washed six times with BSA/PBS solution. The cells were stained with Alexa-568-conjugated goat anti-guinea pig antibody and Alexa-488-conjugated goat anti-rat antibody at 37°C for 40 min. The cells were then washed six times with BSA/PBS solution.
Preparation of double knockdown ES cells
Pdx-1 knockdown cell lines were cultured and induced to differentiate to stage 4; Pdx-1 expression levels were then assayed in the differentiated cells. The cell line with the lowest level of Pdx-1 expression was selected as the recipient of the shRNA Irs-1 expression vector. Similarly, the Irs-1 knockdown cell line with lowest level of Irs-1 expression was selected from each of the two groups using pshRNA Irs-1 -neo(21mer) or pshRNA Irs-1 -neo(29mer). Thus, two cell lines were selected as recipients for the shRNA Pdx-1 expression vector.
Measurement of GSIS
Stage 4 cell clusters were washed four times with DMEM containing 3.3 mM glucose, 10 mM HEPES, and no insulin. After incubation at 37°C for 30 min in the same medium, the cell clusters were washed five times with the same medium to eliminate any residual insulin contamination from the original culture medium. Then Krebs-Ringer solution containing 0, 3.3, or 33 mM glucose was applied to the cell clusters. After incubation at 37°C for 1 h, the insulin concentration in the reaction solution was measured using an Ultrasensitive Mouse Insulin ELISA kit (Mercodia, Uppsala, Sweden).
Criteria for validation of model cell lines
In order to use the developed cell lines as a model system for cell-based tests, it is important to guarantee that the cell lines are thoroughly validated. Here, we used the following criteria for validation:
(1) The expression levels of Pdx-1 and Irs-1 should be sufficient to allow differentiation to stage 4, i.e., to cells capable of producing insulin. The model system was conceived as using cells at this stage, as it was believed that it would not be feasible to simulate more serious dysfunctions that might block differentiation or cause cell death during differentiation. (2) By contrast to criterion (1), the levels of Pdx-1
and Irs-1 expression need to be as low as possible. They should certainly be lower than 50 %, i.e., the heterozygous knockout level, to be able to simulate appreciable dysfunctions in insulin production activity, insulin reception activity, or GSIS activity. (3) The cells should not show any unexpected or abnormal phenotypes, such as unusual expression profiles of diabetes-relevant genes, as a consequence of the Pdx-1 and Irs-1 double knockdown. In the present study, we examined pancreatic cell markers (5 genes), transcription factors (9 genes), and GSIS related genes (3 genes) that are relevant to diabetes.
Results
Pdx-1 and/or Irs-1 knockdown ES cell lines
Ten ES cell colonies carrying the pshRNA Pdx-1 -hygro (21mer) vector were obtained using the hygromycin selection protocol. The levels of Pdx-1 expression were not determined in these candidate Pdx-1 knockdown cell lines as the gene was either not expressed or only expressed at a low level during stages 1-3. Six of the cell lines were selected for differentiation to stage 4, i.e., to the insulin production stage. All 6 cell lines, designated as P-1 to P-6, successfully differentiated to stage 4 and their Pdx-1 expression levels were analyzed by qRT-PCR. The P-1 cell line showed the lowest expression level (32 %) compared to nonvector control cells (Fig. 2a) .
Irs-1 knockdown cell lines were established using the same protocol as above except that G418 was used instead of hygromycin. We obtained 5 colonies with pshRNA Irs-1 -neo(21mer) and 7 colonies with pshRNA Irs-1 -neo(29mer). The cell lines were named I 21 -1 to I 21 -5 and I 29 -1 to I 29 -7, respectively. Examination of Irs-1 expression showed that the I 21 -1 and I 29 -1 cell lines had the lowest expression levels, 19 and 51 %, respectively, compared to non-vector control cells (Fig. 2b) .
Double knockdown cell lines were constructed by introducing the Irs-1 knockdown vector into Pdx-1 knockdown cells, or vice versa. Three recipient cell lines were used, namely P-1, I 21 -1, and I 29 -1. In total, 24 cell lines were established: (1) pshRNA Irs-1 -neo-(21mer) was introduced into P-1 cells to generate 4 lines (P/I 21 -1 to P/I 21 -4); (2) pshRNA Pdx-1 -hygro was introduced into I 21 -1 cells to generate 11 lines (I 21 /P-1 to I 21 /P-11); (3) pshRNA Pdx-1 -hygro was introduced into I 29 -1 cells to generate 9 lines (I 29 /P-1 to I 29 /P-9). The integration of both vectors in each cell line was confirmed by genomic PCR. Each cell line was cultured to form embryoid bodies (stage 2) and Irs-1 expression levels were measured. Two or three cell lines with the lowest levels of Irs-1 expression were selected from each of the three groups. In total, 8 cell lines were finally selected and allowed to differentiate to stage 4. All 8 cell lines successfully differentiated to stage 4. The Pdx-1 and Irs-1 expression levels of each cell line were measured by qRT-PCR. Pdx-1 expression levels ranged from 34 to 77 %, whereas Irs-1 expression levels were in the range 32-46 % (Fig. 2c) . The I 21 /P-1 line showed low levels of Pdx-1 and Irs-1 expression: 34 % for both compared to the non-vector control.
Classification of the cell lines according to gene expression levels (Table 2) indicated that two lines, I 21 /P-1 and P/I 21 -1, were the best candidates for testing of the validation criteria outlined above.
Deficiency of insulin producing activity
Reduction in the Pdx-1 expression level to 32 % caused a reduction in expression of the principal genes for insulin production, Ins1 and Ins2, to 19 % (Fig. 3a) . In contrast, their expression levels increased to 120 % when Irs-1 expression level decreased. In double knockdown cells, Ins1 and Ins2 expression levels were predominantly dependent on the level of Pdx-1 expression (Fig. 3b) . Therefore, Ins1 and Ins2 appear to be less sensitive to variation in expression of Irs-1 than of Pdx-1. The double knockdown cell lines thus satisfy the requirement of an appreciable deficiency in insulin production.
Deficiency of insulin reception signaling function
Deficiency in insulin reception signaling function occurred as a consequence of the knockdown of Irs-1. Therefore, cell lines with low expression levels of Irs-1 (20-40 % compared to the non-vector control) fulfill the criterion of an appreciable deficiency in insulin reception signaling function.
Loss of Irs-1 activity is also known to be compensated by Irs-2 activation. In the present case, expression of Irs-2 was markedly increased by the decrease in Irs-1 expression level (Fig. 4) . In double knockdown cell lines, however, Irs-2 expression decreased. This decrease depended upon the level of Pdx-1 expression rather than that of Irs-1. Therefore, the requirement of an appreciable deficiency in insulin reception signaling function is satisfied in the double knockdown cells.
Deficiency of GSIS activity
The level of Gk expression decreased when the Pdx-1 expression level decreased (Fig. 5a ). There was no difference between Gk expression profiles in single or double knockdown cells, indicating that Gk expression was insensitive to changes in Irs-1 expression.
GSIS activity was measured and, under conditions of no glucose, insulin secretion was observed in all the cell lines. In the absence of glucose, 2.4-2.8 ng/mg protein was secreted; in the presence of 3.3 mM glucose, the level rose to 4.3-5.3 ng/mg protein, and at 33 mM glucose, to 5.0-7.2 ng/mg protein. We designated these levels of insulin secretion at 0, 3.3, and 33 mM glucose as I 0 , I L , and I H , respectively, and constructed a GSIS indicator using the formula: (I H -I 0 )/(I L -I 0 ). As shown in Fig. 5b , the GSIS indicator decreased as Pdx-1 expression level decreased. Therefore, the double knockdown cell lines fulfill P-1 P-2 P-3 P-4 P-5 P-6
Pdx-1 expression level ( Table 2 Cytotechnology (2013) 65:105-118 111 the requirement of an appreciable deficiency of GSIS activity.
Cell cluster sizes and insulin producing patterns These parameters were analyzed to detect a symptom of any malfunction that should occur in cells either during differentiation or at the final stage of insulin producing cells. Three cell lines, P-1, I 21 -1, and I 21 /P-1, were selected on the basis of their low Pdx-1 or Irs-1 expression levels (Table 2) and their properties were compared with those of non-vector control cells. The cell clusters formed by the P-1 and I 21 /P-1 lines, which have low Pdx-1 expression levels, ranged from 85 to 130 lm and were slightly smaller than those of the non-vector control, which ranged from Table 2 Pdx-1 and Irs-1 expression levels in the single and double knockdown cell lines generated in the present study Table 2a , while the broken lines indicate Irs-1 expression profiles obtained with cell lines underlined in Table 2b . b Ins1 (solid lines) and Ins2 (broken lines) expression profiles in WKD cell lines were obtained with cell lines underlined in Table 2c , respectively; these profiles were determined by the least-squares method. Relative gene expression level and error bars are as in Fig. 2 115 to 170 lm (Fig. 6) . By contrast, the clusters in the I 21 -1 line, which has a low Irs-1 expression level, seemed to contain larger clusters which ranged from 115 to 200 lm. The results of this analysis were consistent with those reported previously that the knockdown deficiency of Irs-1 expression is associated with an increase in b-cell mass. Insulin producing activities in the 3 cell lines were analyzed by immunochemical staining. In P-1, which has a relatively low level of Pdx-1 expression (Table 2) , insulin producing activity was lower than in non-vector control cells (Fig. 7) . By contrast, insulin production was similar to that of the nonvector control cells in I 21 -1, which has a relatively low Irs-1 expression level. In the double knockdown cells (I 21 /P-1), the insulin producing pattern was similar to that of Pdx-1 deficient cells (P-1) .
Therefore, the double knockdown cell lines developed here satisfy the requirements that they should not display abnormal phenotypes nor have unusual patterns of insulin producing activity as a consequence of Pdx-1 and Irs-1 knockdown.
Expression profiles of cell type markers
The expression of pancreatic cell markers was investigated in the P-1, I 21 -1, and I 21 /P-1 lines. Five genes were selected, namely Ins2, SS, PP, Glucagon, and Amylase, which respectively act as diagnostic markers for d-cells, PP-cells, a-cells, and exocrine cells. The influence of Pdx-1 and/or Irs-1 knockdown on the expression of these genes is summarized in Table 3a . Expression of all 5 genes was reduced by Pdx-1
Irs-2 expression level (%)
Pdx-1 expression level in WKD cells (%)
Irs-1 expression level in SKD cells (%) Table 2c (closed circle). b GSIS indicator (see text for details) determined using the cell lines underlined in Table 2c (closed circle). Relative gene expression level and error bars are as in Fig. 2 knockdown, but was apparently unaffected by knockdown of Irs-1. Therefore, the increase in cell cluster sizes in I 21 -1 (Fig. 6 ) was unlikely to be a result of an increase in b-cell mass but rather of all cell types. In the double knockdown cell line, I 21 /P-1, expression of the five genes was similar to that in the Pdx-1 single knockdown cell line, P-1. This indicates that suppression of expression of these genes was predominantly a consequence of Pdx-1 knockdown.
Expression profiles of transcription factors
We examined expression of a range of transcription factors that are markers of different cell types from endoderm to pancreatic cells. In the following description, the name of the transcription factor is given in parentheses after the name of the cell type in which it is normally expressed. Endoderm cells (Hnf-1a) differentiate into pancreatic progenitor cells In the P-1 line, with knockdown of Pdx-1, the expression of Ngn3 and Nkx2.2 decreased markedly (Table 3b ). This suggests that differentiation from pancreatic progenitor into endocrine progenitor and further into pancreas b-, d-, and PP-cells was dramatically suppressed. This suppression of differentiation might explain the reduced size of clusters in P-1 (Fig. 6) . By contrast, reduction in Irs-1 expression in the I 21 -1 line did not affect expression of these transcription factors. In the double knockdown cells, I 21 /P-1, the expression profiles of these factors was similar to those in Pdx-1 single knockdown cells. Therefore, the expression of the transcription factors was predominantly regulated by Pdx-1.
Expression profiles of GSIS relevant genes
As mentioned above, Gk is regulated by Pdx-1 expression level. Here, the influence of Pdx-1 and Irs-1 knockdown on other genes associated with GSIS was investigated. As shown in In a similar fashion to that found for the pancreatic cell markers and transcription factors, the expression profiles of GSIS related genes in the double knockdown I 21 /P-1 cell line were similar to those in the Pdx-1 knockdown cell line.
Discussion
In this study, we used RNAi knockdown methodologies to develop knockdown cell lines, rather than the knockout strategies adopted by previous studies on cell lines and mice. At first we would like to discuss the stability of transgenes during long-term culture: the ES cell culture for no longer than 1 month followed by the differentiation culture for ca. 3 weeks. We initiated differentiation culture at different times during the ES cell culture and then measured the expression intensities of Pdx-1 and Irs-1 at stage 4. We confirmed that the knockdown levels of both genes were reproducible within the standard error of means for the repetition of 3 times indicated in Fig. 2 . The results showed that the transgenes were sufficiently stable enough for the quantitative experiments at stage 4. Next we discuss the validation criteria. Here, two cell lines, I 21 /P-1 and P/I 21 -1, were found to meet the necessary validation criteria in order for them to be used as a model cell system. Their characteristics can be summarized as follows:
(i) A decrease in the Pdx-1 expression level reduced Ins1 and Ins2 expression levels (Pdx-1 in Fig. 3a) . This is consistent with previous reports that conclude Pdx-1 is a regulator of Ins1 and Ins2 (Melloul et al. 2001) . (ii) A decrease in the level of expression of Irs-1 increased Irs-2 expression (Irs-1 knockdown cell lines in Fig. 4 ). This is thought to be compensation for the loss of Irs-1 function described e.g. in Kubota et al. (2008) and Dobrzyn et al. (2010) . (iii) A decrease in the level of expression of Pdx-1 reduced Irs-2 expression, and this effect surpassed the reverse effect described above in (ii) as demonstrated in the double knockdown cells (double knockdown cell lines in Fig. 4 ). This observation is a novel finding but does not contradict previous reports Kulkarni et al. (2004) that insufficiency of Pdx-1 limits compensatory islet hyperplasia. (iv) A decrease in the level of expression of Pdx-1 reduced Gk expression (Fig. 5a ). This is consistent with previous reports by Chalk et al. (2004) .
The characteristics of the knockdown cell lines listed above, together with other results obtained in this study, can be explained by the model gene expression regulation scheme illustrated in Fig. 8 .
We have outlined the criteria that candidate cell lines must satisfy before they can be considered as a validated cell model system. Two cell lines, I 21 /P-1 and P/I 21 -1, produced by a double knockdown of Pdx-1 and Irs-1, were shown to satisfy these criteria. The successful generation of these cell lines indicates the feasibility of applying the RNAi method and validation scheme to other combinations of diabetesrelated genes. Therefore, the results of this study will be of general significance for ES cell engineering.
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